These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15729350)

  • 1. India in demand.
    Marris E
    Nature; 2005 Feb; 433(7028):902-3. PubMed ID: 15729350
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemistry's clouded view.
    Smaglik P
    Nature; 2003 Jan; 421(6920):295. PubMed ID: 12529651
    [No Abstract]   [Full Text] [Related]  

  • 3. The quiet rise of the clinical contractor.
    Wadman M
    Nature; 2006 May; 441(7089):22-3. PubMed ID: 16672945
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech as an employer.
    Lawrence S
    Nat Biotechnol; 2007 Jan; 25(1):12. PubMed ID: 17211380
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug discovery--an operating model for a new era.
    Myers S; Baker A
    Nat Biotechnol; 2001 Aug; 19(8):727-30. PubMed ID: 11479559
    [No Abstract]   [Full Text] [Related]  

  • 6. The time is ripe.
    Mortimer M
    Nature; 2007 Jun; 447(7146):884. PubMed ID: 17593575
    [No Abstract]   [Full Text] [Related]  

  • 7. Science and commerce. Chemists for hire: have flask, will travel.
    Alper J
    Science; 2001 Aug; 293(5533):1249-51. PubMed ID: 11509708
    [No Abstract]   [Full Text] [Related]  

  • 8. A chemical imbalance.
    Smaglik P
    Nature; 2002 Jul; 418(6894):3. PubMed ID: 12110846
    [No Abstract]   [Full Text] [Related]  

  • 9. Translating science into business.
    Schuster S
    Nature; 2007 Mar; 446(7135):582. PubMed ID: 17421073
    [No Abstract]   [Full Text] [Related]  

  • 10. In search of the élite.
    Gewin V
    Nature; 2003 Dec; 426(6967):713-7. PubMed ID: 14668879
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnology in the Medicon Valley.
    Frank L
    Nature; 2002 Dec; 420(6916 Suppl):A27, A29, A31 passim. PubMed ID: 12501124
    [No Abstract]   [Full Text] [Related]  

  • 12. Success in an uneven market.
    Russo E
    Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the business of culture.
    Pissarra Pde N
    Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153
    [No Abstract]   [Full Text] [Related]  

  • 14. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood brothers. Alliances between biotechnology and pharmaceutical companies in the U.S.
    Dibner MD
    Biotechnology (N Y); 1993 Oct; 11(10):1120, 1122-3. PubMed ID: 7764092
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech hirings and firings.
    Francisco M
    Nat Biotechnol; 2009 Apr; 27(4):395. PubMed ID: 19352375
    [No Abstract]   [Full Text] [Related]  

  • 17. Founder bows out as genomic firm slashes workforce.
    Wadman M
    Nature; 2004 Apr; 428(6982):456. PubMed ID: 15057797
    [No Abstract]   [Full Text] [Related]  

  • 18. Corridor at the crossroads: Michigan.
    Smaglik P
    Nature; 2002 Nov; 420(6913):4-5. PubMed ID: 12447399
    [No Abstract]   [Full Text] [Related]  

  • 19. Entering the contract research industry in India.
    Joseph J
    Contemp Clin Trials; 2008 May; 29(3):311-3. PubMed ID: 18053773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best of both worlds.
    Smaglik P
    Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.